Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
Clinical trial NCT00341328 · COMPLETED
Trial details
- NCT number
- NCT00341328
- Sponsor
- Ministry of Science and Technology, India
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.